Patents by Inventor Devon Mundal

Devon Mundal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250042906
    Abstract: The present disclosure relates generally to processes for preparing compounds that are inhibitors of the kinase IRAK4 and the synthetic intermediates prepared thereby.
    Type: Application
    Filed: June 28, 2024
    Publication date: February 6, 2025
    Inventors: Stephen E. AMMANN, Angie R. ANGELES, Matthew R. CHIN, Jeromy J. COTTELL, Ian J. DOXSEE, Peter C. FUNG, Brittanie T. HOANG, Stephen LAU, Devon A. MUNDAL, Sean T. NEVILLE, John REICHWEIN, Erik RUEDEN, May G. YOUNG, Chia-Yun YU
  • Publication number: 20250034154
    Abstract: The present disclosure relates to salts and solid forms of a compound that are inhibitors of the kinase IRAK4 and their uses as therapeutic agents for treating diseases, disorders, or conditions modulated by IRAK4, such as inflammatory bowel disease (IBD), systemic lupus erythematosus (SLE), psoriasis, or rheumatoid arthritis.
    Type: Application
    Filed: June 28, 2024
    Publication date: January 30, 2025
    Inventors: Stephen E. AMMANN, Peter C. FUNG, Brittanie T. HOANG, Elizabeth M. HORSTMAN, Stephen LAU, Henry G. MORRISON, Devon A. MUNDAL, May G. YOUNG, Chia-Yun YU
  • Publication number: 20250002484
    Abstract: The present disclosure relates to processes for preparing a compound of formula I: The disclosure also provides compounds that are synthetic intermediates.
    Type: Application
    Filed: February 23, 2024
    Publication date: January 2, 2025
    Inventors: Xiang WANG, Shinji FUJIMORI, Todd Daniel NELSON, Ana Cristina PARRA RIVERA, Devon MUNDAL, Benjamin GRAETZ, Morin M. FRICK
  • Patent number: 11939323
    Abstract: The present disclosure relates to processes for preparing a compound of formula I: The disclosure also provides compounds that are synthetic intermediates.
    Type: Grant
    Filed: May 13, 2022
    Date of Patent: March 26, 2024
    Assignee: Global Blood Therapeutics, Inc.
    Inventors: Xiang Wang, Shinji Fujimori, Todd Daniel Nelson, Ana Cristina Parra Rivera, Devon Mundal, Benjamin Graetz, Morin M. Frick
  • Publication number: 20220388996
    Abstract: The present disclosure relates to processes for preparing a compound of formula I: The disclosure also provides compounds that are synthetic intermediates.
    Type: Application
    Filed: May 13, 2022
    Publication date: December 8, 2022
    Inventors: Xiang Wang, Shinji Fujimori, Todd Daniel Nelson, Ana Cristina Parra Rivera, Devon Mundal, Benjamin Graetz, Morin M. Frick